8-K: Adtalem Global Education Reports Strong Fiscal Year 2024 Results, Initiates Optimistic 2025 Guidance

Adtalem Global Education announced a robust fiscal year 2024 with significant enrollment and revenue growth, and provided an encouraging outlook for fiscal year 2025.

Summary

• Adtalem Global Education reported a strong fiscal year 2024, with revenue reaching $1,584.7 million, a 9.2% increase year-over-year.
• Total student enrollment grew by 10.0% year-over-year in the fourth quarter, reaching 83,321 students.
• Diluted earnings per share for fiscal year 2024 were $3.39, while adjusted EPS was $5.01, reflecting a 19.0% year-over-year growth.
• The company's adjusted EBITDA for the fiscal year was $377.5 million, a 9.9% increase year-over-year.
• Adtalem has initiated fiscal year 2025 guidance, projecting revenue between $1,660 million and $1,700 million, and adjusted earnings per share between $5.60 and $5.85.
• The company repurchased $261 million of shares during the fiscal year and has $212 million remaining under its share repurchase program.
• Adtalem repaid $50 million of its Term Loan B balance and repriced the remaining $253 million, reducing the interest rate by 50 basis points.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong financial results, enrollment growth, and optimistic future guidance. The company's strategic initiatives and capital allocation also contribute to the positive outlook.

Positives

• Adtalem achieved strong enrollment growth across its key institutions, particularly at Chamberlain and Walden Universities.
• The company demonstrated significant revenue growth, with a 9.2% increase for the full fiscal year.
• Adjusted earnings per share saw a substantial 19.0% year-over-year increase, indicating improved profitability.
• The company's adjusted EBITDA also grew by 9.9% year-over-year, reflecting strong operational performance.
• Adtalem's share repurchase program and debt repayment demonstrate effective capital allocation.
• The company's fiscal year 2025 guidance indicates continued growth and profitability.
• The expansion into the Kansas City market and the relocation of the Phoenix campus are positive developments for future growth.

Negatives

• The Medical and Veterinary segment experienced a 2.9% decrease in total student enrollment compared to the prior year.
• The company incurred restructuring expenses related to real estate consolidations.
• There were business acquisition and integration expenses related to the Walden acquisition and growth transformation initiatives.
• The company had a loss from discontinued operations related to the DeVry University and Carrington College divestitures.

Risks

• The company's forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
• The Medical and Veterinary segment's enrollment decline could impact future revenue.
• Restructuring and integration expenses could affect profitability.
• The company's performance is subject to risk factors described in its SEC filings.

Future Outlook

Adtalem projects fiscal year 2025 revenue to be between $1,660 million and $1,700 million, and adjusted earnings per share to be between $5.60 and $5.85.

Management Comments

• Steve Beard, president and chief executive officer, stated that fiscal year 2024 was a fundamental chapter in Adtalem's journey, solidifying their market leading position in healthcare education.
• Steve Beard also mentioned that the company is confident that fiscal year 2025 will set new benchmarks for Adtalem.

Industry Context

Adtalem's strong performance reflects the growing demand for healthcare education in the United States, positioning the company as a leader in this sector. The expansion of programs and campuses aligns with the industry's need for a larger and more skilled healthcare workforce.

Comparison to Industry Standards

• Adtalem's 9.2% revenue growth for fiscal year 2024 is strong compared to the overall education sector, which has seen more modest growth.
• The 19% growth in adjusted EPS is also impressive, indicating strong profitability compared to peers in the for-profit education industry.
• Companies like Strategic Education, Inc. and Grand Canyon Education, Inc. are comparable in the for-profit education space, and Adtalem's enrollment growth and financial metrics are competitive.
• The expansion of Chamberlain University and Walden University, along with the new campus locations, positions Adtalem well against competitors in the healthcare education market.

Stakeholder Impact

• Shareholders will benefit from the strong financial performance and share repurchase program.
• Employees will be impacted by the company's growth and expansion.
• Students will benefit from the expansion of programs and campuses.
• The company's community impact in Barbados will benefit local nurses.

Next Steps

• Adtalem will continue to execute its Growth with Purpose strategy.
• The company will expand into the Kansas City market with a new Chamberlain location.
• Walden University will continue to enhance its digital learning platform throughout fiscal year 2025.
• Adtalem will hold a conference call to discuss its fiscal 2024 fourth quarter and fiscal year results.

Key Dates

Keywords

Adtalem Global Education, Healthcare Education, Enrollment Growth, Revenue Growth, Adjusted EPS, Adjusted EBITDA, Financial Results, Fiscal Year 2024, Fiscal Year 2025 Guidance, Chamberlain University, Walden University